NCT00006238: Phenylbutyrate in Treating Children With Progressive or Recurrent Cancer of the Central Nervous System |
|
|
| Active, not recruiting | 2 | | US | sodium phenylbutyrate | Texas Children's Cancer Center, National Cancer Institute (NCI) | Brain and Central Nervous System Tumors | | | | |
NCT06069375: Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) |
|
|
| Recruiting | 2 | 24 | US | Sodium phenylbutyrate, Olpruva | Jerry Vockley, MD, PhD, Acer Therapeutics Inc. | Medium-chain Acyl-CoA Dehydrogenase Deficiency | 06/25 | 12/25 | | |
